Japan's Medical And Biologic Laboratories To Expand CTL Immunotherapy In China
This article was originally published in PharmAsia News
Executive Summary
Aichi-based Medical and Biological Laboratories plans to commence clinical study for immunotherapy using cytotoxic T lymphocyte in China in September